Skip to main content

Animations

MJFF Publications

4761 - 4770 of 6564 Results
Title
Year
  • Year
  • 2026
  • 2016
  • 2023
  • 2019
  • 2022
  • 2017
  • 2015
  • 2019
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: Protocol to study synapse density or volume—SynDOVE—in brain using confocal microscopy and Imaris three-dimensional surface rendering software
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2026.104465
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.08.023
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.23016
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease
    Journal Name: Current Opinion in Physiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future Applications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13503
    Citation Count: 1
  • Summary Details
    OPEN
    Title: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.13937
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Structural Characterization of LRRK2 Inhibitors
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jm5018779
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Falling down the digital divide: A cautionary tale
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.032
    Citation Count: 5
  • Summary Details
    OPEN
    Title: RAB32 Variants in a German Parkinson's Disease Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mds.30005
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.